Catalyst Wire Dossier Catalyst Wire Dossier

AUS vaccine combination (Tetanus, Diphtheria, Acellular Pertussis) with meningococcal vaccine

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AUS vaccine combination (Tetanus, Diphtheria, Acellular Pertussis) with meningococcal vaccine, covering 2017-03-16 to 2017-03-16. Get the full timeline:

Most recent: Clinical Trial Update: US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease [Phase 4]

See pricing